Angiotensin II vs Big Endothelin-1 — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
Angiotensin II is the principal effector peptide of the renin-angiotensin-aldosterone system (RAAS), a master regulator of blood pressure, fluid balance, and cardiovascular function. Generated by sequential cleavage of angiotensinogen by renin (producing Ang I) then by angiotensi...
Calculate Angiotensin II dose →Big endothelin-1 (big ET-1) is a 38-amino acid peptide that is the direct precursor to the potent vasoconstrictor endothelin-1 (ET-1). It is produced by vascular endothelial cells from preproendothelin-1 and cleaved to the active 21-amino acid ET-1 by endothelin-converting enzyme...
Calculate Big Endothelin-1 dose →| Parameter | Angiotensin II | Big Endothelin-1 |
|---|---|---|
| Category | Vasoactive Peptide | Vasoactive Peptide |
| Research | Clinical | Preclinical/Biomarker |
| Half-Life | 30 seconds - 2 minutes (plasma) | Longer than ET-1 (~plasma half-life 3-5 min ET-1) |
| Typical Dose | 20-40 ng/kg/min (vasopressor) | Research only |
| Frequency | Continuous infusion in clinical use | N/A |
| Route | Intravenous (continuous infusion) | Endogenous; IV (research) |
| FDA Status | Approved (Giapreza, vasodilatory shock) | No approval |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.